Document is current

Article History

Received: 11 December 2024

Revised: 16 January 2025

Accepted: 19 January 2025

First Online: 12 February 2025

Declarations

:

: The present study has been approved by the Hospital de la Santa Creu i Sant Pau ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all participants prior to their inclusion in the study.

: A.P.-D. is supported by a grant from the Government of Andorra (ATC027-AND/2021). S.M.-H. has received honoraria for lecturing from Teva, Zambon, UCB, Bial, and Roche, and reports grants from Huntington’s disease Society of America (Human Biology Project), and from Fondo de Investigaciones Sanitarias (FIS) from Instituto de Salud Carlos III (ISCIII). J.P.-P. reports a grant from Fondo de Investigaciones Sanitarias (FIS) from Instituto de Salud Carlos III (ISCIII). JP has received honoraria for advisory boards or lecturing from: Teva, Zambon, UCB, Bial, Sanofi, and Roche. J.K. has received honoraria for advisory boards or lecturing from: Teva, Zambon, UCB, Bial, General Electric, Sanofi, and Roche, and reports grants from Fundació la Marato de TV3, Fondo de Investigaciones Sanitarias (FIS) from Instituto de Salud Carlos III (ISCIII), and Fondo Europeo de Desarrollo Regional (FEDER). The authors declare that there is no conflict of interest regarding the publication of this article. The research group also receives funds from CERCA (CEntres de Recerca de CAtalunya) and CIBERNED (Centro de Investigación Biomédica en Red de enfermedades NEuroDegenerativas).